PROJECT SUMMARY
Diseases such as osteoporosis and periodontal disease affect millions of individuals annually in the United
States and cost billions in treatment. Osteoclasts are large, multinucleated cells that secrete acid and
proteases to resorb bone. Understanding the molecular mechanisms that regulate osteoclast differentiation
and activity will provide insight as to how the hyper-active osteoclasts causing pathological bone loss,
contributes to osteoporosis and periodontal disease. Reversible modifications to DNA such as histone
acetylation, methylation, phosphorylation and ubiquitylation alter the access of transcriptional machinery to
DNA and regulate gene expression. Lysine-specific demethylase 1 (LSD1), also known as KDM1A, is the first
identified histone demethylase capable of specially demethylating mono- and di-methylated lysine 4 of histone
3 (H3K4me1/2) or lysine 9 of histone 3 (H3K9me1/2). LSD1 confers transcriptional repression by
demethylating H3K4 or activating transcription by demethylating H3K9. The mechanism by which LSD1
regulates osteoclast gene expression and differentiation is currently unknown. Preliminary data presented in
this proposal demonstrate inhibition of LSD1 activity or expression leads to an increase in mono-methylation of
H3K4me1 and an increase in osteoclast differentiation. These preliminary data suggest LSD1 is a repressor of
osteoclast gene expression. This proposal aims to characterize the role of LSD1 in regulating osteoclast
differentiation in both an animal model and as well as in an in vitro cell culture model (Aim 1) and identifying
the osteoclast genes that are regulated by LSD1 (Aim 2). These research goals will be enhanced by the
training goals of the application. These training goals include learning techniques such as micro-CT, RNA-SEQ
and ChIP-SEQ as well as participation in journal clubs and local and national scientific meetings. Training
takes place at the University of Minnesota which offers an outstanding environment for both research and
clinical dental training.
Public Health Relevance Statement
PROJECT NARRATIVE
Osteoclasts are cells that break down bone during normal growth and repair, playing a significant role in bone
destructive diseases like osteoporosis, periodontal disease, cancer, and arthritis. This project aims to determine
if lysine-specific demethylase 1 (LSD1), a protein that regulates osteoclast formation by removing methyl groups
from histones, inhibits osteoclast formation and activity. Understanding the molecular mechanisms governing
the activity of LSD1 may lead to development of pharmaceutical treatments for diseases associated with
increased bone resorption.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
555917996
UEI
KABJZBBJ4B54
Project Start Date
29-August-2020
Project End Date
28-August-2025
Budget Start Date
29-August-2024
Budget End Date
28-August-2025
Project Funding Information for 2024
Total Funding
$54,774
Direct Costs
$54,774
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Dental and Craniofacial Research
$54,774
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5F30DE030354-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F30DE030354-05
Patents
No Patents information available for 5F30DE030354-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F30DE030354-05
Clinical Studies
No Clinical Studies information available for 5F30DE030354-05
News and More
Related News Releases
No news release information available for 5F30DE030354-05
History
No Historical information available for 5F30DE030354-05
Similar Projects
No Similar Projects information available for 5F30DE030354-05